Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 117.00
Bid: 116.00
Ask: 121.50
Change: 0.00 (0.00%)
Spread: 5.50 (4.741%)
Open: 117.00
High: 0.00
Low: 0.00
Prev. Close: 117.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheduled Trading Statement

8 Jul 2019 07:00

RNS Number : 7147E
Xaar PLC
08 July 2019
 

Xaar plc

 

Scheduled Trading Statement

 

Xaar plc ("Xaar" or the "Group"), a world leader in industrial inkjet technology, provides its scheduled trading update for the six months ended 30 June 2019.

Trading is in line with the Board's expectations and Xaar expects to report revenue of approximately £23 million for the six months ended 30 June 2019. Overall revenue for the first half was £27 million however this was impacted by approximately £4 million of revenue reversal regarding Xaar 1201 inventory being returned to the business. We anticipate selling this inventory in the second half of the year. Cash at 30 June 2019 was £21.6 million.

Excluding one-time Royalties of approximately £10 million in H1 2018 and the prior years' revenue reversal of approximately £4 million in H1 2019, revenue grew by 8%.

Underlying trading in the Printhead business has stabilised after the declines of 2018 with growth in the Industrial and Packaging segments. Growth in Industrials came from Ceramics, Décor and Advanced Manufacturing, while in Packaging growth came from Coding and Marking. As referenced above, approximately £4 million revenue in the Graphics segment has been reversed due to Xaar 1201 inventory being returned for rework due to age. We have subsequently regained control of this inventory in order to drive payment recovery and explore broader channel options. Key new printhead products have shown good growth in the first half; Xaar 2001 (43%), Xaar 501 (88%) and in particular Xaar 5601 (490%) which continues to be very positively received by customers as recently witnessed at the ITMA textile printing show in Barcelona.

Our Product Print Systems business grew by 41% driven by growth in inkjet and pad printing equipment as well as consumables.

Xaar 3D Printing is on plan with strong positive customer feedback for our new printer and we continue to work closely with Stratasys on the next phase of our partnership.

Cash balances of £21.6 million at 30 June 2019 are in line with expectations, reflecting the improved working capital profile of the business. We continue to work diligently at improving our working capital and anticipate further progress through the second half of the year.

 

We have advanced on our strategic review of the Thin Film business and will provide an update on progress at the half year results due to be announced on 10 September 2019.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

Doug Edwards, Chief Executive Officer

Shomit Kenkare, Chief Financial Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

David Ison

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development, and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKDLFBKDFLBBB
Date   Source Headline
16th Jul 20207:00 amRNSTrading Statement
9th Jul 20204:36 pmRNSPrice Monitoring Extension
1st Jul 20203:17 pmRNSConfirmation of Board Change & Succession
1st Jul 202011:47 amRNSTotal Voting Rights
5th Jun 20207:00 amRNSGrant of Options
2nd Jun 202011:16 amRNSTotal Voting Rights
2nd Jun 202011:13 amRNSResult of AGM
2nd Jun 20207:00 amRNSTrading Statement
15th May 202010:59 amRNSHolding(s) in Company
7th May 20207:00 amRNSNotice of Annual General Meeting
1st May 20203:10 pmRNSTotal Voting Rights
30th Apr 20202:27 pmRNSHolding(s) in Company
29th Apr 202012:04 pmRNSDisclosure of Rights attached to Equity Shares
29th Apr 202011:41 amRNSGrant of option
28th Apr 20205:27 pmRNSHolding(s) in Company
27th Apr 20202:23 pmRNSHolding(s) in Company
27th Apr 20202:00 pmRNSDirectorate Change - Appointment
24th Apr 20203:10 pmRNSHolding(s) in Company
24th Apr 20203:02 pmRNSAnnual Financial Report
23rd Apr 20202:35 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSAnnual Financial Report
9th Apr 20209:15 amRNSHolding(s) in Company
6th Apr 20203:35 pmRNSHolding(s) in Company
1st Apr 20202:49 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSConfirmation of Board Changes and Succession
23rd Mar 20205:47 pmRNSTrading Statement-COVID-19 & Preliminary Statement
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 20208:41 amRNSHolding(s) in Company
2nd Mar 202011:38 amRNSTotal Voting Rights
25th Feb 20207:41 amRNSHolding(s) in Company
18th Feb 20201:04 pmRNSHolding(s) in Company
13th Feb 20204:57 pmRNSHolding(s) in Company
12th Feb 20205:25 pmRNSHolding(s) in Company
3rd Feb 202012:41 pmRNSTotal Voting Rights
16th Jan 20207:00 amRNSTrading Statement
9th Jan 20207:00 amRNSDirectorate Change
8th Jan 202011:09 amRNSHolding(s) in Company
3rd Jan 20203:32 pmRNSBlock listing Interim Review
2nd Jan 20202:15 pmRNSTotal Voting Rights
10th Dec 20193:51 pmRNSHolding(s) in Company
4th Dec 20194:53 pmRNSCompletion of Investment by Stratasys in Xaar 3D
2nd Dec 20195:39 pmRNSTotal Voting Rights
27th Nov 201910:35 amRNSResult of General Meeting
19th Nov 20199:23 amRNSHolding(s) in Company
18th Nov 20193:32 pmRNSHolding(s) in Company
8th Nov 20194:15 pmRNSPublication - Circular & Notice of General Meeting
1st Nov 201912:50 pmRNSTotal Voting Rights
23rd Oct 20198:30 amRNSHolding(s) in Company
23rd Oct 20198:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.